Back Article

  • Baay M F, Tjalma W A, Weyler J. Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer[J]. Eur J Gynaecol Oncol, 2001, 22(): 204-208.

  • Bergeron C, Barrasso R, Beaudenon S. Human papillomaviruses associated with cervical intrae-pithelial neoplasia. Great diversity and distinct distribution in low-and high-grade lesions[J]. Am J Surg Pathol, 1992, 16(): 641-649. doi: 10.1097/00000478-199207000-00002

  • Bosch F X, Manos M M, Munoz N. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group[J]. J Natl Cancer Inst, 1995, 87(): 796-802. doi: 10.1093/jnci/87.11.796

  • Brown D R, Schroeder J M, Bryan J T. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients[J]. J Clin Microbiol, 1999, 37(): 3316-3322.

  • Buck C B, Pastrana D V, Lowy D R. Efficient intracellular assembly of papillomaviral vectors[J]. J Virol, 2004, 78(): 751-757. doi: 10.1128/JVI.78.2.751-757.2004

  • Calleja-Macias IE, Kalantari M, Allan B. Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and -b[J]. J Virol, 2005, 78(): 6565-6569.

  • Carter J J, Galloway D A. Humoral immune response to human papillomavirus infection[J]. Clin Dermatol, 1997, 15(): 249-259. doi: 10.1016/S0738-081X(97)00068-0

  • Carter JJ, Koutsky LA, Hughes JP. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection[J]. J Infect Dis, 2000, 181(): 1911-1919. doi: 10.1086/jid.2000.181.issue-6

  • Chan S Y, Bernard H U, Ong C K. Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses[J]. J Virol, 1992, 66(): 5714-5725.

  • Christensen N D, Kreider J W, Shah K V. Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions[J]. J Gen Virol, 1992, 73(5): 1261-1267. doi: 10.1099/0022-1317-73-5-1261

  • Cui M H, Liu Y Q, Li H L. Human papillomavirus in condyloma acuminata and other benign lesions of the female genital tract[J]. Chin Med J (Engl), 1994, 107(): 703-708.

  • de Villiers E M, Fauquet C, Broker T R. Classification of papillomaviruses[J]. Virology, 2004, 324(): 17-27. doi: 10.1016/j.virol.2004.03.033

  • Ferrera A, Velema J P, Figueroa M. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study[J]. Int J Cancer, 1999, 82(): 799-803. doi: 10.1002/(ISSN)1097-0215

  • Gissmann L. Immunologic responses to human papillomavirus infection[J]. Obstet Gynecol Clin North Am, 1996, 23(): 625-639.

  • Huang S, Afonina I, Miller B A. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women[J]. Int J Cancer, 1997, 70(): 408-411. doi: 10.1002/(ISSN)1097-0215

  • Leiserowitz GS, Hall KS, Foster CA. Detection of serologic neutralizing antibodies against HPV-11 in patients with condyloma acuminata and cervical dysplasiausing an in vitro assay[J]. Gynecol Oncol, 1997, 66(): 295-299. doi: 10.1006/gyno.1997.4743

  • Lo K W, Wong Y F, Chan M K. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China[J]. Int J Cancer, 2002, 100(): 327-331. doi: 10.1002/(ISSN)1097-0215

  • Pastrana D V, Buck C B, Pang Y Y. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18[J]. Virology, 2004, 321(): 205-216. doi: 10.1016/j.virol.2003.12.027

  • Phelps W C, Alexander K A. Antiviral therapy for human papillomaviruses: rational and prospects[J]. Ann Intern Med, 1995, 123(): 368-382. doi: 10.7326/0003-4819-123-5-199509010-00008

  • Schellekens M C, Dijkman A, Aziz M F. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia[J]. Gynecol Oncol, 2004, 93(): 49-53. doi: 10.1016/j.ygyno.2003.12.015

  • Sigurdsson K, Taddeo F J, Benediktsdottir K R. HPV genotypes in CIN 2-3 lesions and cervical cancer: a population-based study[J]. Int J Cancer, 2007, 121(): 2682-2687. doi: 10.1002/(ISSN)1097-0215

  • Stewart A C, Eriksson A M, Manos M M. Intratype variation in 12 human papillomavirus types: a worldwide perspective[J]. J Virol, 1996, 70(): 3127-3136.

  • zur H H, de Villiers E M. Human papillomaviruses[J]. Annu Rev Microbiol, 1994, 48(): 427-447. doi: 10.1146/annurev.mi.48.100194.002235